Pentosan polysulfate sodium 100 mg + Placebo + Pentosan polysulfate sodium 100 mg
ApprovedTerminated 1 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Interstitial Cystitis
Conditions
Interstitial Cystitis
Trial Timeline
Sep 1, 2003 → Jun 1, 2011
NCT ID
NCT00086684About Pentosan polysulfate sodium 100 mg + Placebo + Pentosan polysulfate sodium 100 mg
Pentosan polysulfate sodium 100 mg + Placebo + Pentosan polysulfate sodium 100 mg is a approved stage product being developed by Johnson & Johnson for Interstitial Cystitis. The current trial status is terminated. This product is registered under clinical trial identifier NCT00086684. Target conditions include Interstitial Cystitis.
What happened to similar drugs?
0 of 4 similar drugs in Interstitial Cystitis were approved
Approved (0) Terminated (1) Active (3)
Hype Score Breakdown
Clinical
20
Activity
0
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00086684 | Approved | Terminated |
Competing Products
20 competing products in Interstitial Cystitis